Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease

BACKGROUND: Accurate and timely diagnosis of Alzheimer’s disease (AD) is important for prompt initiation of treatment in patients with AD and to avoid inappropriate treatment of patients with false-positive diagnoses. METHODS: Using a Markov model, we estimated the lifetime costs and quality-adjuste...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Spencer A. W., Sposato, Luciano A., Hachinski, Vladimir, Cipriano, Lauren E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356269/
https://www.ncbi.nlm.nih.gov/pubmed/28302164
http://dx.doi.org/10.1186/s13195-017-0243-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356269/
https://www.ncbi.nlm.nih.gov/pubmed/28302164
http://dx.doi.org/10.1186/s13195-017-0243-0

Ejemplares similares